Bacil Pharma Ltd is in Pharmaceutical businessOperational Status: Company is non operational for the past many years. It has not carried out any major business activity and management is considering diversifying their business activities and have deployed surplus funds as temporary loans and advances
Notice of Annual General Meeting to be held on 23rd September, 2026
BACIL Pharma has set its book closure period from September 17 to September 23 for the upcoming 39th Annual General Meeting. During this period, only shareholders registered on record by the close of business on September 16 will be eligible to attend and vote at the AGM, which is scheduled...
Bacil Pharma's board approved the 39th AGM. Key items include a boost in authorized share capital from ₹20 Cr to ₹70 Cr. Leadership moves include Chaitali Shah's MD re-designation and several director regularizations, plus a new auditor.
Bacil Pharma (BACPHAR) has announced a board meeting on Aug 29th. The agenda includes discussions for the 39th AGM notice, approval of the FY26 Director Report, and finalizing the AGM's date, place, and timing.
